Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,300 | 2,281 | 4,005 | 5,787 | 5,737 |
| Receivables | 61 | 170 | 238 | 358 | 224 |
| TOTAL | $7,966 | $2,708 | $4,538 | $6,508 | $6,506 |
| Non-Current Assets | |||||
| PPE Net | 52 | 63 | 76 | 90 | 107 |
| Intangibles | 688 | 713 | 738 | 764 | 789 |
| Other Non-Current Assets | 237 | 37 | 53 | 322 | 319 |
| TOTAL | $977 | $814 | $867 | $1,176 | $1,215 |
| Total Assets | $8,944 | $3,522 | $5,406 | $7,685 | $7,721 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,181 | 1,052 | 1,083 | 833 | 836 |
| Other current liabilities | 400 | 20 | 127 | 219 | 349 |
| TOTAL | $1,581 | $1,071 | $1,210 | $1,051 | $1,185 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 320 | 488 | 924 | 584 | 2,057 |
| TOTAL | $320 | $488 | $924 | $584 | $2,057 |
| Total Liabilities | $1,901 | $1,559 | $2,134 | $1,635 | $3,242 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 0 | 0 | 0 | 0 |
| Common Shares | 28 | 10 | 182 | 9 | 152 |
| Retained earnings | -219,938 | -218,175 | -216,738 | -213,624 | -213,304 |
| Other shareholders' equity | -8 | -3 | -2 | 0 | 1 |
| TOTAL | $7,043 | $1,963 | $3,272 | $6,050 | $4,479 |
| Total Liabilities And Equity | $8,944 | $3,522 | $5,406 | $7,685 | $7,721 |